Doha Declaration and Compulsory License for Access to Medicines
AbstractThe Doha Declaration provides for access to medicines particularly by simplifying the compulsory licensing (CL) clause. This paper tries to provide a comprehensive review of the working of CL in the developed and developing countries with some useful case studies. [GIDR WP No. 184].
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by eSocialSciences in its series Working Papers with number id:2216.
Date of creation: Sep 2009
Date of revision:
Note: Institutional Papers
Contact details of provider:
Web page: http://www.esocialsciences.org
compulsory licensing; CL; HIV AIDS; developed; developing countries; case studies; medicines; doha; declaration; Indian companies; drugs; patients; India; Anti-cancer drugs; prices;
This paper has been announced in the following NEP Reports:
- NEP-ALL-2009-10-03 (All new papers)
- NEP-CWA-2009-10-03 (Central & Western Asia)
- NEP-HEA-2009-10-03 (Health Economics)
You can help add them by filling out this form.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Padma Prakash).
If references are entirely missing, you can add them using this form.